脑部放疗，上午比下午敏感许多！$ F4 m) N% P. Z, |* b/ ]1 `
% C& T8 c5 l: r6 O& b* [0 Z, E9 O: ]% c! A! ]
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
; \6 p3 ?2 u$ g3 ~5 P% o' L$ FGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?5 \) U5 l+ H8 T& r' P/ g6 b9 m
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
4 y" A0 ]- O/ F VSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.) O! H% p9 l% I1 U9 j, ?$ g, _8 H
, ^) q" a0 x8 K& T4 G6 VAbstract, [, S) k0 o, L% t. P
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.* T8 C6 r- T5 D
2 g$ p, b9 O) P X5 u# T/ u
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
! H f- r* J1 A2 [' t2 [
" S3 O+ K0 H7 rRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
) s3 q0 o) K* O1 k- c" g7 U, g2 i# E, I( P6 t, h: q/ x+ y
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
+ X' I1 Z3 n! }" z" ~: [* M* k
3 W/ U: o2 a% X l' ] |
显身卡
